Kaley Wilson Ph.D

Kaley Wilson Ph.D General Information

Biography

Dr. Kaley Wilson served as Board Member at Iome Bio. She served as Director of Business Development at Quark Venture. She served as a Board Member at SeraGene Therapeutics and Canary Medical. She served as Interim Chief Executive Officer & Board Member at Sitka Biopharma. She also served as Chief Executive Officer at ARTMS Products. In her previous role as Associate Director of partnerships, at the Centre for Drug Research and Development, she worked in tandem with CDRD's President CEO, and Executive Team playing a key role in building and maintaining the organization's strategic alliances and partnerships with industry, academia, government, foundations, and other organizations which were critical to CDRD realizing its vision of transforming the culture of scientific innovation and commercialization impacting human health. She was also a key member of CDRD's Project Search and Evaluation Team on which she leads the identification and evaluation of drug discovery projects with potential therapeutic value in the areas of infection, inflammation, and immunity - her areas of scientific expertise. She obtained her PhD at the University of British Columbia (UBC), Canada, where she worked in close collaboration with senior scientists at INEX Pharmaceuticals on the immunomodulatory activity and vaccine potential of lipid-encapsulated nucleic acids. She is the author of five publications two review articles and an inventor on one patent. During her Ph.D. She was the recipient of several prestigious scholarships and awards including the Doctoral Research Award, from the Canadian Institutes for Health Research (2005-2008); the Trainee Research Award, from Michael Smith Foundation for Health Research (2003-2005), and the PGS-A Scholarship, NSERC (2002-2004). She was also the 2008 recipient of the Gattefosse Canada/Canadian Society for Pharmaceutical Sciences Research Award. She was also a member of the Advisory Board for the Neglected Global Diseases Initiative, a UBC-based organization dedicated to developing interventions for neglected global diseases and ensuring their delivery to those in need. She serves as a Board Member at Microbion.